Research Project

Project Title:

DUPLEX

Project Type:

Clinical Trial, Enrolment ongoing
Adjunct biobank: Serum, Plasma, Urine

Disease group(s):

Immune glomerulopathies

Project Summary:

A Randomized, Multicenter, Double blind, Parallel, Active control Study of the Effects
of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal
Outcomes in Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)

Lead principal investigator(s):

Mai Rosenberg, Tartu

Co-investigator(s):

Kristi Veermäe, Tartu

Project Period:

10/2018   -   12/2023

Sponsors:

Industry

Project web page:

https://www.fsgsduplex.com/#!/

ClinicalTrials.gov:

NCT03493685

« Back to research page